The Department of Oncology, which includes the CRUK/MRC Oxford Institute for Radiation Oncology, has an established world-leading graduate training programme for science graduates and clinical research fellows under the leadership of Professor Mark Middleton.
It is one of the largest departments in the University of Oxford’s Medical Sciences Division. It houses over 400 staff and graduate students, both clinical and non-clinical, and brings together research and clinical groups from across Oxford who are based at the Old Road Campus Research Building (ORCRB), the Radiobiology Research Institute (RRI), the Weatherall Institute for Molecular Medicine (WIMM) and the NHS Cancer and Haematology Centre.
The department has a broad area of research interests in the fields of oncology, including DNA damage and repair, tumour microenvironment and metastasis, angiogenesis and hypoxia, cancer immunology, molecular determinants of radiosensitivity or resistance, experimental radiation therapeutics and cancer imaging and gene therapy in particular virotherapy of advanced cancer.
The Department of Oncology offers promising graduates a broad range of multidisciplinary and translational cancer research projects. As a result, its graduates come from a wide range of scientific backgrounds, including biology, medicine, engineering, mathematics, chemistry and physics and the department prides itself on supporting and training the next generation of world leaders in cancer research to ensure its research continues over the long term.